Selection and characterization of a DNA Aptamer that can discriminate between cJun/cJun and cJun/cFos

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Walters, Ryan D ^a   McSwiggen, David T ^a   Goodrich, James A ^a   Kugel, Jennifer F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; INTERLEUKIN 2; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC2; UNCLASSIFIED DRUG; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; DNA PROTEIN COMPLEX; GENE REPRESSION; GENE TARGETING; NUCLEOTIDE BINDING SITE; PROTEIN DNA BINDING; REPORTER GENE; ANIMAL; BINDING SITE; CELL LINE; CHEMISTRY; CONFORMATION; GENETICS; METABOLISM; PROMOTER REGION; PROTEIN MULTIMERIZATION; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE;

ANIMALS; APTAMERS, NUCLEOTIDE; BINDING SITES; CELL LINE; GENES, REPORTER; INTERLEUKIN-2; NUCLEIC ACID CONFORMATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; SELEX APTAMER TECHNIQUE; TRANSCRIPTION FACTOR AP-1;

EID: 84903395865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101015     Document Type: Article

References (32)

1. Karin M, Liu Z, Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246. (Pubitemid 27135992)
2. Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nature Rev Cancer 3: 859-868. (Pubitemid 37383716)
3. Behre G, Whitmarsh AJ, Coghlan MP, Hoang T, Carpenter CL, et al. (1999) c-Jun is a JNK-independent coactivator of the PU. 1 transcription factor. J Biol Chem 274: 4939-4946.
4. Grondin B, Lefrancois M, Tremblay M, Saint-Denis M, Haman A, et al. (2007) c-Jun homodimers can function as a context-specific coactivator. Mol Cell Biol 27: 2919-2933. (Pubitemid 46581307)
5. Walters RD, Drullinger LF, Kugel JF, Goodrich JA (2013) NFATc2 recruits cJun homodimers to an NFAT site to synergistically activate interleukin-2 transcription. Mol Immunol 56: 48-56.
6. Van Dam H, Castellazzi M (2001) Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 20: 2453-2464. (Pubitemid 32531302)
7. Wisniewska MB, Ameyar-Zazoua M, Bakiri L, Kaminska B, Yaniv M, et al. (2007) Dimer composition and promoter context contribute to functional cooperation between AP-1 and NFAT. J Mol Biol 371: 569-576. (Pubitemid 47087826)
8. Bakiri L, Matsuo K, Wisniewska M, Wagner EF, Yaniv M (2002) Promoter specificity and biological activity of tethered AP-1 dimers. Mol Cell Biol 22: 4952-4964. (Pubitemid 34620427)
9. Fennewald SM, Scott EP, Zhang L, Yang X, Aronson JF, et al. (2007) Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections. J Gen Virol 88: 981-990. (Pubitemid 46359569)
10. Chen SY, Cai C, Fisher CJ, Zheng Z, Omwancha J, et al. (2006) c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Oncogene 25: 7212-7223. (Pubitemid 44764190)
11. Hettinger K, Vikhanskaya F, Poh MK, Lee MK, De Belle I, et al. (2006) c-Jun promotes cellular survival by suppression of PTEN. Cell Death Differ 14: 218-229. (Pubitemid 46092225)
12. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
13. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
14. Ferguson HA, Goodrich JA (2001) Expression and purification of recombinant human c-Fos/c-Jun that is highly active in DNA binding and transcriptional activation in vitro. Nucl Acids Res 29: E98.
15. Darty K, Denise A, Ponty Y (2009) VARNA: Interactive drawing and editing of the RNA secondary structure. Bioinformatics 25: 1974.
16. Chinenov Y, Kerppola TK (2001) Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20: 2438-2452. (Pubitemid 32531301)
17. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31: 3406-3415.
18. Balasubramanian B, Pogozelski WK, Tullius TD (1998) DNA strand breaking by the hydroxyl radical is governed by the accessible surface areas of the hydrogen atoms of the DNA backbone. Proc Natl Acad Sci U S A 95: 9738-9743. (Pubitemid 28415239)
19. Macian F, Lopez-Rodriguez C, Rao A (2001) Partners in transcription: NFAT and AP-1. Oncogene 20: 2476-2489. (Pubitemid 32531304)
20. Nguyen TN, Kim LJ, Walters RD, Drullinger LF, Lively TN, et al. (2010) The C-terminal region of human NFATc2 binds cJun to synergistically activate interleukin-2 transcription. Mol Immunol 47: 2314-2322.
21. Nimjee SM, Rusconi CP, Sullenger BA (2005) Aptamers: an emerging class of therapeutics. Annu Rev Med 56: 555-583. (Pubitemid 40299797)
22. Brody EN, Gold L (2000) Aptamers as therapeutic and diagnostic agents. Rev Mol Biotech 74: 5-13.
23. Zhao X, Shi H, Sevilimedu A, Liachko N, Nelson HC, et al. (2006) An RNA aptamer that interferes with the DNA binding of the HSF transcription activator. Nucl Acids Res 34: 3755-3761. (Pubitemid 44400424)
24. Fan X, Shi H, Adelman K, Lis JT (2004) Probing TBP interactions in transcription initiation and reinitiation with RNA aptamers that act in distinct modes. Proc Natl Acad Sci U S A 101: 6934-6939. (Pubitemid 38596421)
25. Shi H, Fan X, Sevilimedu A, Lis JT (2007) RNA aptamers directed to discrete functional sites on a single protein structural domain. Proc Natl Acad Sci U S A 104: 3742-3746. (Pubitemid 47181525)
26. Park MW, Choi KH, Jeong S (2005) Inhibition of the DNA binding by the TCF-1 binding RNA aptamer. Biochem Biophys Res Commun 330: 11-17. (Pubitemid 40403023)
27. Kroeger PE, Morimoto RI (1994) Selection of new HSF1 and HSF2 DNA-binding sites reveals difference in trimer cooperativity. Mol Cell Biol 14: 7592-7603. (Pubitemid 24326425)
28. Cho J-S, Lee YJ, Shin K-S, Jeong S, Park J, et al. (2004) In vitro selection of specific RNA aptamers for the NFAT DNA binding domain. Mol Cells 18: 17-23. (Pubitemid 39386650)
29. Kim LJ, Ferguson HA, Seto AG, Goodrich JA (2000) Characterization of DNA binding, transcriptional activation, and regulated nuclear association of recombinant human NFATp. BMC Immunol 1: 1.
30. Lebruska LL, Maher LJ (1999) Selection and characterization of an RNA decoy for transcription factor NF-κB. Biochemistry 38: 3168-3174.
31. Huang D-B, Vu D, Cassiday LA, Zimmerman JM, Maher LJ, et al. (2003) Crystal structure of NF-κB (p50) 2 complexed to a high-affinity RNA aptamer. Proc Natl Acad Sci U S A 100: 9268-9273. (Pubitemid 37033918)
32. Reiter NJ, Maher L Jr, Butcher SE (2008) DNA mimicry by a high-affinity anti-NF-kappaB RNA aptamer. Nucl Acids Res 36: 1227-1236. (Pubitemid 351330940)